Computational Drug Repurposing: Current Trends.

Area of Science:

• Computational biology
• Pharmacology
• Bioinformatics

Background:

• The digitization of biomedical data from diverse sources like clinical pharmacology and cheminformatics is revolutionizing drug discovery.
• Supercomputing and integrated biological, physicochemical, and clinical data enable detailed mapping of signaling pathways and drug mechanisms.
• Advancements in computer-aided data mining and 'big data' approaches accelerate the identification of new indications for existing drugs.

Purpose of the Study:

• To review common computational drug repurposing strategies.
• To highlight the integration of large-scale systems biology data using bioinformatics and cheminformatics tools.
• To discuss the challenges and opportunities in computational drug repurposing.

Main Methods:

• Integration of biological, physicochemical, and clinical data.
• Application of bioinformatics and cheminformatics tools.
• Analysis of gene-phenotype associations and molecular structure information.
• Utilizing systems biology approaches.

Main Results:

• Computational strategies accelerate drug discovery and improve drug repurposing success.
• Linking gene-phenotype associations can predict novel drug-disease signatures.
• Incorporating molecular and systems biology data enhances prediction of new therapeutic uses.
• Successful examples and case studies demonstrate the efficacy of in silico drug repurposing.

Conclusions:

• Computational drug repurposing, integrating diverse data through bioinformatics and cheminformatics, offers significant potential for accelerating drug discovery.
• Systems biology approaches combined with in silico strategies are crucial for identifying novel uses of existing therapeutics.
• Despite challenges, computational methods provide a powerful framework for optimizing drug repurposing efforts.